Which AI chatbot is the biggest liar?
ADVERTISEMENT
ADVERTISEMENT
More about this topic
The slimming shot: What price are you willing to pay for a dream body?
How weight loss demand is draining Europe’s diabetes drug supply, as countries adopt varying speeds of approach to medicinal approval for dual purposes.
Experimental daily pill shows promising results in aiding weight loss
Other weight loss drugs must be injected, meaning the new pill from pharmaceutical giant Eli Lilly could become patients’ top choice if it is approved.
1 in 5 UK adults estimated to have diabetes in new record high
More than 1 million adults in the UK have type 2 diabetes but have not been diagnosed, according to the newly-released report.
UK pharmacies urge tougher rules for online sales of weight loss drugs
The pharmacy association said it was worried some patients were accessing the drugs inappropriately amid a surge in demand.
ADVERTISEMENT
Scientists unveil benefits and risks of blockbuster weight-loss drugs
While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health outcomes.
England to roll out new anti-obesity drug but only for some patients
The drug is expected to cost €381.1 million per year within three years.
Childhood diabetes rates are rising globally. How does Europe compare?
A Nordic country has the world’s highest rate of childhood type 1 diabetes, according to a new analysis.
Reduced sugar intake in early life linked to lower risk of disease
Limiting sugar intake from conception through early childhood was linked to lower risks of type 2 diabetes and hypertension, a new study found.
Weight-loss jabs may help patients stop smoking but trials needed
A new study looked at the influence of popular weight-loss drugs on medical care related to tobacco use.
More people worldwide are suffering from neurological issues than ever
Researchers warn the cost to health systems around the world will be severe if more is not done to prevent and treat these diseases.
How much higher can Novo Nordisk shares go?
Novo Nordisk's remarkable ascent, driven by its revolutionary weight-loss drug Wegovy, has led to a surge in market value and positive analyst outlook.
Euroviews. Infecting animals with diabetes won’t save human lives
This World Diabetes Day, it’s high time all experiments on animals used to study the condition were replaced with humane, human-relevant research, Dr Julia Baines writes.
Sales skyrocket for weight-loss drug firm Novo Nordisk
The Danish drugmaker expects double-digit growth to continue into 2024 as demand soars for obesity and diabetes medication.
Patients hospitalised after using counterfeit weight-loss drugs
Austria’s health authorities said they had reports that Ozempic counterfeit medicine had reached patients. UK regulators also said a small number of patients were hospitalised.
Scientists develop eye implants that could treat diabetes
A 3D-printed, microscale implant in the eye that uses pancreatic cells could help to treat diabetes and other diseases.
1.3 billion could suffer from diabetes by 2050 in ‘global crisis’
Structural racism and global inequalities are also accelerating soaring rates of diabetes disease, illness and death, researchers said.